Then, we analyzed whether GARP expression levels were associated with clinicopathological features, including gender, age, tumor size (T), lymph node metastasis (N), distant metastasis (M), TNM stage, tumor differentiation, preoperative serum carcinoembryonic antigen (CEA) levels, and preoperative serum carbohydrate antigen 19-9 (CA19-9) levels. The gene discussed is LRRC32; the disease is neoplasm.